André Furco
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 4
- Virology 4
- HIV Research and Treatment 3
- Rabies epidemiology and control 1
- Co-authors
- Jean‐Michel Molina (5 shared papers)A. Bourgarit (1 shared paper)Alexandre Karras (1 shared paper)D Droz (1 shared paper)Frank Martinez (1 shared paper)Matthieu Lafaurie (1 shared paper)Christophe Legendre (1 shared paper)D. Séréni (1 shared paper)
In The Last Decade
André Furco
11 papers receiving 410 citations
Peers
Comparison fields: 5 of 49
- Virology 112
- Infectious Diseases 265
- Emergency Medicine 109
- Hepatology 43
- Epidemiology 169
Countries citing papers authored by André Furco
This map shows the geographic impact of André Furco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Furco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Furco more than expected).
Fields of papers citing papers by André Furco
This network shows the impact of papers produced by André Furco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Furco. The network helps show where André Furco may publish in the future.
Co-authors
The 25 scholars most cited alongside André Furco, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 279 | |
| 2 | 2005 | 73 | |
| 3 | 2007 | 17 | |
| 4 | 2008 | 12 | |
| 5 | [Pulmonary mucormycosis: benefit of aerosol amphotericin B?]. | 2001 | 12 |
| 6 | [Metastatic cancer of the prostate in a 40-year-old HIV-infected male patient]. | 2003 | 11 |
| 7 | 2005 | 9 | |
| 8 | 2006 | 8 | |
| 9 | 2023 | 2 | |
| 10 | [Treatment interruption in 30 HIV-infected patients with successful viral suppression under highly active antiretroviral treatment]. | 2005 | 2 |
| 11 | 2005 | 1 |
About André Furco
André Furco is a scholar working on Infectious Diseases, Virology, Epidemiology, Surgery and Oncology, having authored 11 papers that have together received 426 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (4 papers), HIV Research and Treatment (3 papers), HIV-related health complications and treatments (2 papers), Viral-associated cancers and disorders (2 papers), Metabolism and Genetic Disorders (1 paper), Oral and gingival health research (1 paper), Cytomegalovirus and herpesvirus research (1 paper) and Rabies epidemiology and control (1 paper). The work is most often cited by research in Virology (112 citations), Infectious Diseases (265 citations), Emergency Medicine (109 citations), Hepatology (43 citations) and Epidemiology (169 citations). André Furco has collaborated with scholars based in France, Singapore and Canada. Frequent co-authors include Jean‐Michel Molina, A. Bourgarit, Alexandre Karras, D Droz, Frank Martinez, Matthieu Lafaurie, Christophe Legendre, D. Séréni, Jean‐Marc Gornet and Christophe Hennequin. Their work appears in journals such as Clinical Infectious Diseases, HIV Medicine, AIDS, Diseases of the Colon & Rectum and Antiviral Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.